Evaluation of BioStar FLU OIA assay for rapid detection of influenza A and B viruses in respiratory specimens
- PMID: 10942092
- DOI: 10.1016/s1386-6532(00)00081-0
Evaluation of BioStar FLU OIA assay for rapid detection of influenza A and B viruses in respiratory specimens
Abstract
Background: Demand for the rapid diagnosis of influenza infections has increased with the advent of the availability of neuraminidase antiviral therapy for influenza A and B. Several rapid assays that detect both influenza A and B are now available.
Objectives: In this study we compared the performance of the BioStar FLU OIA assay to Bartels Viral Respiratory Screening and Identification Kit (Bartels Inc., Issaquah, WA), and cell culture.
Study design: A total of 145 patient specimens for influenza virus detection submitted in either viral transport medium or in sterile containers were evaluated by the three methods. Specimen types included nasal washings, nasal swabs, sputum, throat swabs, and bronchial alveolar lavage (BAL) fluids.
Results: Fifty six positive specimens were identified based on culture and/or DFA. Of these, 30 specimens were positive by the OIA assay for an overall sensitivity of 54%. The OIA assay detected 48% (n = 21) of the 44 culture positive specimens and 81% (n = 29) of the 36 DFA positive specimens. Eighty six of the 89 culture/DFA negative samples were negative by the OIA assay (97% specificity). Analysis of the OIA assay sensitivity from samples submitted in M4 transport medium or in sterile containers revealed that M4 transport medium does not reduce the sensitivity of the OIA assay. Fifteen of the 27 positive samples submitted in M4 transport medium were positive by the OIA assay (56% sensitivity) compared to 15 of 29 positive samples transported in sterile containers (52% sensitivity). Twelve specimens were either culture and/or DFA positive for viruses other than influenza, but negative by the OIA assay, suggesting that there was no cross reactivity of the OIA assay with the other virus types recovered in this study.
Conclusions: The overall excellent specificity of the BioStar FLU OIA allows for treatment of positive patients for influenza, however, a negative result should be confirmed by DFA and culture.
Similar articles
-
Comparison of four clinical specimen types for detection of influenza A and B viruses by optical immunoassay (FLU OIA test) and cell culture methods.J Clin Microbiol. 1999 Dec;37(12):3971-4. doi: 10.1128/JCM.37.12.3971-3974.1999. J Clin Microbiol. 1999. PMID: 10565916 Free PMC article.
-
[Optical immunoassay test for rapid detection of influenza A and B viruses: an evaluation].Kansenshogaku Zasshi. 1999 Oct;73(10):1069-73. doi: 10.11150/kansenshogakuzasshi1970.73.1069. Kansenshogaku Zasshi. 1999. PMID: 10565124 Japanese.
-
Simultaneous detection and typing of influenza viruses A and B by a nested reverse transcription-PCR: comparison to virus isolation and antigen detection by immunofluorescence and optical immunoassay (FLU OIA).J Clin Microbiol. 2001 Jan;39(1):134-8. doi: 10.1128/JCM.39.1.134-138.2001. J Clin Microbiol. 2001. PMID: 11136761 Free PMC article.
-
[The rapid detection kit based on neuraminidase activity of influenza virus].Nihon Rinsho. 2000 Nov;58(11):2234-7. Nihon Rinsho. 2000. PMID: 11225310 Review. Japanese.
-
A flu optical immunoassay (ThermoBioStar's FLU OIA): a diagnostic tool for improved influenza management.Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1915-24. doi: 10.1098/rstb.2001.1005. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11779392 Free PMC article. Review.
Cited by
-
Comparison of the Denka-Seiken INFLU A.B-Quick and BD Directigen Flu A+B kits with direct fluorescent-antibody staining and shell vial culture methods for rapid detection of influenza viruses.J Clin Microbiol. 2003 May;41(5):2180-3. doi: 10.1128/JCM.41.5.2180-2183.2003. J Clin Microbiol. 2003. PMID: 12734274 Free PMC article.
-
Bedside rapid flu test and zanamivir prescription in healthy working adults: a cost-benefit analysis.Pharmacoeconomics. 2003;21(3):215-24. doi: 10.2165/00019053-200321030-00006. Pharmacoeconomics. 2003. PMID: 12558471
-
Role of cell culture for virus detection in the age of technology.Clin Microbiol Rev. 2007 Jan;20(1):49-78. doi: 10.1128/CMR.00002-06. Clin Microbiol Rev. 2007. PMID: 17223623 Free PMC article. Review.
-
Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16.Euro Surveill. 2018 Feb;23(7):17-00026. doi: 10.2807/1560-7917.ES.2018.23.7.17-00026. Euro Surveill. 2018. PMID: 29471622 Free PMC article.
-
The limitations of point of care testing for pandemic influenza: what clinicians and public health professionals need to know.Can J Public Health. 2009 May-Jun;100(3):204-7. doi: 10.1007/BF03405541. Can J Public Health. 2009. PMID: 19507723 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical